US Medicare Keeps Spending More on COVID-19 Testing. Fraud and Overspending Are Partly Why.
Anjeanette Damon (ProPublica) 03 January 2023
This story was originally published by ProPublica.
 
As the COVID-19 pandemic continues to churn, Medicare spending on testing for the virus continued to increase in 2022 and is outpacing the two prior years.
 
Through Oct. 31, Medicare had spent $2 billion on COVID-19 tests in 2022, an amount that will surpass last year’s total as claims are filed, according to new data provided to ProPublica by CareSet, a research organization that works to make the health care system more transparent.
 
That compares to $2 billion for all of 2021 and $1.5 billion in 2020, a recent analysis by the Department of Health and Human Services’ Office of Inspector General shows.
 
Fraud and overspending are contributing to the increases, experts say, because federal money for COVID-19 testing is not subject to some of the same financial and regulatory constraints as other tests covered by Medicare, the government insurance program for people 65 and older and the disabled.
 
The growing costs concern some of these experts, who say the need for financial incentives to expand the availability of testing has passed.
 
Early in the pandemic, testing was both critical to slowing the spread of the virus and in short supply. So the federal government enacted measures to make it more profitable to get in the COVID-19 testing business. Good for the duration of the public health emergency, which has not yet expired, the measures include a generous Medicare reimbursement rate, requirements for private insurance to cover testing — even compelling insurance plans to pay whatever cash price is demanded by out-of-network labs — and a hefty fund for testing those people who didn’t have insurance.
 
The measures succeeded in drawing new and existing labs into the COVID-19 business and helped ensure most people had access to testing, even if some faced excessive waits to get their results. But the incentives also attracted price-gougers, fraudsters and people with no experience in the laboratory business. The result was a chaotic approach that ranged from bungled testing programs and confusion over new requirements to outright fraud.
 
“It was an unprecedented wave of fraud,” said Michael Cohen, an operations officer with the HHS Inspector General, which investigates crimes involving federal health care programs.
 
This year, ProPublica detailed how one Chicago-based lab, Northshore Clinical, used political connections in Nevada to speed its licensing and generated tremendous volume through agreements with school districts, universities and local governments. The story also detailed questionable billing practices that one insurance expert described as fraudulent. A study of Northshore’s testing on the University of Nevada Reno campus found the company missed 96% of COVID-19 cases during December 2021.
 
The company submitted 600 pages of documentation to state regulators to support its claim that it fixed deficiencies noted by inspectors, but it ultimately asked the state to close its license and pulled out of Nevada before the investigation was finished. Northshore repeatedly declined to comment to ProPublica.
 
The OIG, which had been investigating Northshore in Illinois, expanded its probe to Nevada after ProPublica published its report.
 
Cohen said OIG investigators have faced challenges responding to the onslaught of suspected fraud — from a lack of additional resources to constantly evolving policies.
 
In April, the Department of Justice announced criminal charges against people in eight states who allegedly submitted more than $149 million in COVID-19 false billings to federal programs. The OIG has also performed analyses on Medicare data, including for a report released this month that found 378 labs had billed Medicare for expensive add-on tests at “questionably high levels” after testing individuals for COVID-19.
 
Attorneys general in a handful of states have taken action against labs for forging results, charging fees for “expedited results” that arrived days later and deceptive marketing practices.
 
Programs to pay for COVID-19 testing aren’t the only pandemic assistance funds that have attracted people seeking to profit. Paycheck Protection Program loans went to fake businesses or were spent on luxury goods instead of keeping people employed, ProPublica and other news outlets have reported. Expanded state unemployment programs also saw unprecedented fraud that a partial accounting estimates is $57.3 billion.
 
Tolerating some fraud is a necessary trade-off to attain legitimate public policy goals, said Loren Adler, associate director of the USC-Brookings Schaeffer Initiative for Health Policy. But once the incentives and loose regulations boosted the availability of testing, they could have been revised to prevent abuse and overspending, he argued. Continue Reading
 
Comments
groupstonath
4 weeks ago
Very much correct. On a visit to U S in July 2022 I was tested for covid by RTPCR method (which proved negative)I was charged $ 800 to my astonishment. I could neither afford it nor did pay it since I was a visitor. Some companies must be making a fast buck this way!
Food delivery platform Grubhub to pay $3.5 mn for misleading customers
IANS 02 January 2023
Popular online food delivery platform Grubhub will pay $3.5 million for charging customers hidden fees and using deceptive marketing techniques to increase profits in violation of consumer protection laws in the...
FTX: The Bahamas seizes US$3.5bn in digital assets as ex-CEO Sam Bankman-Fried faces trial
IANS 31 December 2022
The government in The Bahamas has seized $3.5 billion in FTX digital assets, as its former CEO Sam Bankman-Fried faces a trial in the US.
 
The country's Securities Commission took control of the assets soon after the crypto...
Pele, the legend who made football 'the beautiful game' is no more
IANS 30 December 2022
Called by various names such as 'Gasolina', 'The Black Pearl' and 'O Rei' (The King), the nickname that stuck like glue to Edson Arantes do Nascimento, who, as 'Pele', became the greatest footballer the world has ever...
Uzbekistan Claims 18 Children Die after Consuming Cough Syrup Made by Noida-based Marion Biotech
IANS 29 December 2022
The Uzbekistan government has alleged that 18 children have died in the central Asian nation following the consumption of a cough syrup produced by an Indian pharmaceutical firm Marion Biotech.
 
"To date, 18 out of 21...
Free Helpline
Legal Credit
Feedback